Skip to main
  1. Stocks
  2. Cigna
  3. Forecast
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 25%
Buy 44%
Hold 31%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is positioned well because its 3Q26 results showed resilient execution, with adjusted EPS of $7.98 beating consensus by $0.48 as CignaHealthcare pretax adjusted operating income reached $1.2B versus $1.1B expected and Evernorth was modestly ahead. Management reinforced confidence by raising CY26 adjusted EPS guidance to at least $30.60, lifting CignaHealthcare operating income guidance to above $4.6B, and setting a CY27 adjusted EPS floor of $33.00, supported by stop-loss recovery, stable medical cost trends, and strong selling season momentum. Its long-duration earnings thesis is further backed by high-90% PBM retention, the Centene win, a large DoD contract base, and the $3B Accelerate to One savings target by 2030, which should drive margin expansion and earnings durability.

Bears say

Cigna Group is facing a weakening fundamental outlook because its CignaHealthcare exit from the Individual ACA in 1/1/27 removes a business that generated $3.2B of CY26 premium revenue and about $113.3M of pretax adjusted operating income, creating an estimated ($0.60) CY27 adjusted EPS headwind. At the same time, Evernorth’s Pharmacy Benefit Services faces a CY27 rebating and GLP-1 headwind that could cut PBS pretax adjusted operating income by about $241.8M, while Specialty and Care Services is only expected to grow at the low end of its 8.0%-12.0% long-term target range. With management also warning of rebate-pool compression, stranded costs, and execution risk around pricing healthcare cost trend and biosimilar adoption, the company’s earnings base looks more fragile despite a large employer and government customer footprint.

Cigna (CI) has been analyzed by 16 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 44% recommend Buy, 31% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Cigna (CI) Analyst Forecast & Price Prediction

Get the latest Cigna (CI) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Cigna (CI)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 16 analysts, Cigna (CI) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $341.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $341.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Cigna (CI) Analyst Forecast & Price Prediction

Get the latest Cigna (CI) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Cigna (CI)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover CI stock data and trends